Cargando…

E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial

Detalles Bibliográficos
Autores principales:	Bewersdorf, Jan Philipp, Stahl, Maximilian, Taylor, Justin, Mi, Xiaoli, Chandhok, Namrata Sonia, Watts, Justin, Derkach, Andriy, Wysocki, Mateusz, Lu, Sydney X., Bourcier, Jessie, Hogg, Simon J., Rahman, Jahan, Chaudhry, Sana, Totiger, Tulasigeri M., Abdel-Wahab, Omar, Stein, Eytan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681888/ https://www.ncbi.nlm.nih.gov/pubmed/37814121 http://dx.doi.org/10.1038/s41375-023-02050-4

Ejemplares similares

Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
por: Faust, Tyler, et al.
Publicado: (2019)

Protein biomarkers for response to XPO1 inhibition in haematologic malignancies
por: Totiger, Tulasigeri M., et al.
Publicado: (2023)

Targeted Therapy Development in Acute Myeloid Leukemia
por: Totiger, Tulasigeri M., et al.
Publicado: (2023)

Arginine reprograms metabolism in liver cancer via RBM39
por: Mossmann, Dirk, et al.
Publicado: (2023)

Overlaid Transcriptional and Proteome Analyses Identify Mitotic Kinesins as Important Targets of Arylsulfonamide-Mediated RBM39 Degradation
por: Coomar, Seemon, et al.
Publicado: (2023)

Lung Inflammation Predictors in Combined Immune Checkpoint-Inhibitor and Radiation Therapy—Proof-of-Concept Animal Study
por: Spieler, Benjamin, et al.
Publicado: (2022)

Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker
por: Zhang, Rui, et al.
Publicado: (2022)

Toward prediction of abscopal effect in radioimmunotherapy: Pre-clinical investigation
por: Mihaylov, Ivaylo B., et al.
Publicado: (2021)

Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39
por: Campagne, Sébastien, et al.
Publicado: (2023)

RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5
por: Loiselle, Julie J., et al.
Publicado: (2017)

RBM39 Alters Phosphorylation of c-Jun and Binds to Viral RNA to Promote PRRSV Proliferation
por: Song, Yinna, et al.
Publicado: (2021)

Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models
por: Singh, Shivendra, et al.
Publicado: (2021)

Evaluation of α(2)-Integrin Expression as a Biomarker for Tumor Growth Inhibition for the Investigational Integrin Inhibitor E7820 in Preclinical and Clinical Studies
por: Keizer, Ron J., et al.
Publicado: (2011)

The small-molecule protein ligand interface stabiliser E7820 induces differential cell line specific responses of integrin α2 expression
por: Hülskamp, Michael David, et al.
Publicado: (2021)

Negative autoregulation of BMP dependent transcription by SIN3B splicing reveals a role for RBM39
por: Faherty, Noel, et al.
Publicado: (2016)

Insights into novel emerging epigenetic drugs in myeloid malignancies
por: Chandhok, Namrata S., et al.
Publicado: (2019)

Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy
por: Tong, Jia, et al.
Publicado: (2020)

Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells
por: Chen, Wei-Ching, et al.
Publicado: (2021)

The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress
por: Lemaitre, Florence, et al.
Publicado: (2022)

Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)
por: Nguyen, Nina, et al.
Publicado: (2022)

Rbm24a and Rbm24b Are Required for Normal Somitogenesis
por: Maragh, Samantha, et al.
Publicado: (2014)

The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination
por: Xia, Anliang, et al.
Publicado: (2023)

Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay
por: Sun, Yue, et al.
Publicado: (2017)

RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours
por: Wang, Ke, et al.
Publicado: (2007)

Enhanced anti-angiogenic effect of E7820 in combination with erlotinib in epidermal growth factor receptor–tyrosine kinase inhibitor-resistant non-small-cell lung cancer xenograft models
por: Ito, Ken, et al.
Publicado: (2014)

Alternative Splicing of Cdh23 Exon 68 Is Regulated by RBM24, RBM38, and PTBP1
por: Li, Nana, et al.
Publicado: (2020)

Deconstructing Protein Binding of Sulfonamides and Sulfonamide Analogues
por: Purder, Patrick L., et al.
Publicado: (2023)

New Insights in RBM20 Cardiomyopathy
por: Lennermann, D., et al.
Publicado: (2020)

iPSC Modeling of RBM20-Deficient DCM Identifies Upregulation of RBM20 as a Therapeutic Strategy
por: Briganti, Francesca, et al.
Publicado: (2020)

A bacterial virulence factor interacts with the splicing factor RBM5 and stimulates formation of nuclear RBM5 granules
por: Pourpre, Renaud, et al.
Publicado: (2022)

Sulfonamide Allergies
por: Giles, Amber, et al.
Publicado: (2019)

RBM5 reduces small cell lung cancer growth, increases cisplatin sensitivity and regulates key transformation-associated pathways
por: Loiselle, Julie J., et al.
Publicado: (2016)

RBM19 is essential for preimplantation development in the mouse
por: Zhang, Jian, et al.
Publicado: (2008)

Alternative Splicing Regulator RBM20 and Cardiomyopathy
por: Watanabe, Takeshi, et al.
Publicado: (2018)

RBM25 Mediates Abiotic Responses in Plants
por: Cheng, Chunhong, et al.
Publicado: (2017)

RBM10: Structure, functions, and associated diseases
por: Inoue, Akira
Publicado: (2021)

A Genetic Screen for Pre-mRNA Splicing Mutants of Arabidopsis thaliana Identifies Putative U1 snRNP Components RBM25 and PRP39a
por: Kanno, Tatsuo, et al.
Publicado: (2017)

Molecular characteristics and outcomes in Hispanic and non‐Hispanic patients with acute myeloid leukemia
por: Bradley, Terrence, et al.
Publicado: (2022)

Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site
por: Tessier, Sarah J, et al.
Publicado: (2015)

Comparison of the removal torque and a histomorphometric evaluation of the RBM treated implants with the RBM followed by laser treated implants: an experimental study in rabbits
por: Park, Eun Young, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j6ts1f2j2ds5iakrl59u02ftpf